Pfizer Inc (PFE)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	-17,800,000	-6,774,000	4,877,000	15,085,000	16,373,000	15,970,000	14,391,000	8,361,000	3,385,000	4,276,000	-1,246,000	-4,435,000	-5,396,000	-7,503,000	-6,189,000	-4,809,000	-5,087,000	-4,436,000	-3,542,000	-3,884,000
Revenue (ttm)	US$ in thousands	58,497,000	68,538,000	77,944,000	92,952,000	100,331,000	100,771,000	101,921,000	92,738,000	81,285,000	63,407,000	51,332,000	44,201,000	41,650,000	47,096,000	47,667,000	49,131,000	50,098,000	51,534,000	52,176,000	52,443,000
Operating profit margin		-30.43%	-9.88%	6.26%	16.23%	16.32%	15.85%	14.12%	9.02%	4.16%	6.74%	-2.43%	-10.03%	-12.96%	-15.93%	-12.98%	-9.79%	-10.15%	-8.61%	-6.79%	-7.41%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-17,800,000K ÷ $58,497,000K
= -30.43%

Pfizer Inc.'s operating profit margin has shown fluctuations over the past eight quarters. The operating profit margin declined from 37.15% in Q4 2022 to 5.74% in Q4 2023. However, there was a notable increase in the margin in Q1 2023 to 36.25%, followed by a further increase in Q2 2023 to 30.09% and a peak at 15.51% in Q3 2023. The margin in the most recent quarter, Q4 2023, decreased significantly to 5.74%. Overall, Pfizer's operating profit margin has been volatile, with a general upward trend in the first half of 2023 followed by a sharp decline in the last quarter. It is essential for stakeholders to closely monitor these trends and understand the underlying factors impacting the company's profitability.